Migraine is a nervous system disorder that causes intense headaches that can last between 4 and 72 hours. While the exact cause of migraines is unknown, several factors can trigger these episodes. Besides headaches, they can induce nausea, vomiting, and blurry vision. It can also make one sensitive to light and sound. While migraines are chronic, there are several treatment options, Vyepti being the most popular one, to prevent attacks and alleviate symptoms.

How Vyepti works
Calcitonin gene-related peptide, or CGRP is a protein that has been found to contribute to migraines. In fact, this protein is also known to cause inflammation in the body. When CGRP is released in the brain, it activates the receptors that send pain signals by attaching to them, leading to headaches. Plus, during migraines, the release of CGRP in the brain can worsen the headaches and make them last longer.

Vyepti works by preventing CGRP from activating these pain receptors in the brain. It is given as an intravenous infusion. Vyepti components bind to CGRP and prevent it from attaching to the receptors. This keeps the pain receptors from activating and consequently prevents migraine attacks.

Benefits of Vyepti
Vyepti is quite beneficial to those who experience frequent bouts of migraine attacks.

– Gets absorbed quickly
Since Vyepti is given as an intravenous (IV) infusion, it can be absorbed into the bloodstream. This means the treatment can begin working quickly once it is in the body.

– Is approved by the FDA
Vyepti is the first and, for now, the only FDA-approved IV infusion treatment for migraine prevention.

– Has a long-lasting effect
The treatment is long-lasting; a single infusion causes fewer migraine attacks for the next three months.

– Can be taken anywhere
Another benefit of Vyepti infusion is that it can be received anywhere, whether at a clinic, a dedicated infusion center, or at home.

– Requires no downtime
Unlike other IV infusion therapies, the Vyepti infusion does not require downtime. As soon as one is done taking the infusion, one can carry on with their routine.

Vyepti results
It was noted in clinical trials that Vyepti greatly reduced monthly migraine days for those experiencing chronic and episodic migraines.

– For chronic migraines
A few adults who experienced chronic migraines, with an average of 16 migraines in a month, showed significant improvement after receiving Vyepti infusions; they experienced eight fewer migraine days per treatment.

– For episodic migraines
These migraines cause fewer headache days in a month than chronic migraines, about 4 to 14 days a month. Adults with episodic migraines, who experienced an average of nine migraine days in a month, also showed a lot of improvement after being treated with Vyepti —on average, they experienced four fewer migraine days in a month.